| scholarly article | Q13442814 |
| P50 | author | Rochelle P. Walensky | Q34445539 |
| Elena Losina | Q55523364 | ||
| Kenneth A. Freedberg | Q87347438 | ||
| Bruce R Schackman | Q90916815 | ||
| P2093 | author name string | B Wang | |
| M Smurzynski | |||
| P E Sax | |||
| R J Bosch | |||
| J Rong | |||
| J Schouten | |||
| B P Linas | |||
| P2860 | cites work | Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 |
| Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons | Q28274676 | ||
| Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial | Q28298301 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care | Q31153755 | ||
| Inpatient health services utilization among HIV-infected adult patients in care 2002-2007. | Q33699011 | ||
| The survival benefits of AIDS treatment in the United States | Q34533291 | ||
| Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis | Q37122490 | ||
| AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics | Q37246041 | ||
| Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection | Q39526550 | ||
| Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. | Q41612046 | ||
| Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group | Q43036483 | ||
| Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients | Q43969654 | ||
| Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy | Q44836883 | ||
| AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States | Q45203047 | ||
| Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus | Q45383108 | ||
| Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study | Q45389079 | ||
| Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study | Q45397541 | ||
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study | Q45413375 | ||
| Trends in health care resource use for hepatitis C virus infection in the United States | Q45422078 | ||
| Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy | Q45424761 | ||
| Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis | Q45736423 | ||
| A Perceived Health Index for use in persons with advanced HIV disease: derivation, reliability, and validity. | Q46043360 | ||
| Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. | Q53608173 | ||
| Derivation and properties of a brief health status assessment instrument for use in HIV disease | Q72553132 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | disability | Q12131 |
| P304 | page(s) | 506-512 | |
| P577 | publication date | 2010-06-09 | |
| P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
| P1476 | title | The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort | |
| P478 | volume | 18 |
| Q34227450 | Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men. |
| Q34735072 | Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs |
| Q35154639 | Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study |
| Q36379622 | HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms |
| Q36184653 | Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection |
| Q57101679 | Hospitalization Trends and Comorbidities Among People With HIV/AIDS Compared With the Overall Hospitalized Population, Illinois, 2008-2014 |
| Q45149386 | Medical ward admissions among HIV-positive patients in Winnipeg, Canada, 2003-10. |
| Q34873781 | National trends in hospitalization and mortality rates for patients with HIV, HCV, or HIV/HCV coinfection from 1996-2010 in the United States: a cross-sectional study |
| Q26864478 | Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation |
| Q37305565 | Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease |
| Q38760372 | Physical function, grip strength and frailty in people living with HIV in sub-Saharan Africa: systematic review |
| Q36399193 | Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis |
| Q38120496 | Protease inhibitors for hepatitis C: economic implications |
| Q46955676 | Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men. |
| Q49823266 | Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy |
| Q37046208 | Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease |
| Q37252421 | Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV |
| Q33710740 | The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients |
| Q35572125 | The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection |
| Q33632459 | The hepatitis C cascade of care: identifying priorities to improve clinical outcomes |
| Q55339576 | The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study. |
Search more.